Hib Bacterial Disease Resurges as Vaccination Rates Decline

For those of us living and working in Lubbock, Texas, the recent warnings about the return of Haemophilus influenzae type b (Hib) aren’t just abstract headlines—they hit close to home. While many of us view the current healthcare landscape through the lens of modern convenience, the reality is that a deadly bacterial infection, once nearly eradicated by vaccination, is making a comeback. In a city where the community often gathers around the halls of Texas Tech University or the bustling corridors of the South Plains, the risk of a vaccine-preventable disease resurging is a sobering reminder that public health is a fragile equilibrium.

The Quiet Return of a Forgotten Threat

Hib is a fast-moving, highly contagious bacterial infection that can lead to devastating outcomes, including meningitis and epiglottitis. To understand the gravity of the current situation, one only needs to look at the history of the disease before the vaccine became widely available. Prior to the introduction of the Hib vaccine, approximately 20,000 children in the United States—primarily infants and toddlers—developed severe forms of the infection every year. The toll was immense: about 1,000 children died annually, and many survivors were left with permanent brain damage.

The narrative of Hib is a testament to the power of immunization. After vaccines were introduced, the number of infections plummeted to fewer than 50 cases per year. Though, this success has created a paradox of perception. Because many physicians trained over the last four decades have never encountered a live case of Hib, and because parents today have not witnessed the frightening effects of the disease, there is a growing trend of opting out of vaccinations. This “vaccine slump” is manifesting in the data; according to the CDC, the percentage of babies receiving all their Hib shots dropped from 78.8% in 2019 to 77.6% in 2021.

The Local Connection: A Warning from Lubbock

The danger is vividly illustrated by the experience of Dr. Lara Johnson, the current chief medical officer at Covenant Children’s Hospital in Lubbock. Long before she was leading a medical institution in the Hub City, Dr. Johnson was a victim of the disease. At age four, in 1980, she contracted Hib, which attacked her epiglottis—the cartilage that prevents food from entering the lungs. The infection caused her airway to close, leaving her unable to swallow and feeling as though she were choking. She required an emergency tracheostomy, where doctors had to cut through her neck into her windpipe just so she could breathe. Her recovery was possible through antibiotics and surgical intervention, but the scar on her neck remains a permanent reminder of a time before the Hib vaccine existed.

Understanding the CDC Vaccination Framework

To combat this resurgence, the Centers for Disease Control and Prevention (CDC) maintains a strict immunization schedule. The primary goal is to protect children younger than five years old, as they are the most vulnerable to the bacteria. For those navigating the healthcare system in Texas, it is essential to understand the specific timing of these doses to ensure full protection.

The CDC recommends a primary series starting at age 2 months. Depending on the specific vaccine used, this typically involves three doses of ActHIB®, Hiberix®, Pentacel®, or Vaxelis™, or two doses of PedvaxHIB®. In some cases, providers can administer the first dose as early as 6 weeks. A critical component of this schedule is the booster dose, administered between 12 and 15 months of age. This booster must be given at least 8 weeks after the most recent vaccination. While Vaxelis™ is used for the primary series at 2, 4, and 6 months, it is not indicated for use as a booster dose.

For those who have fallen behind on the schedule, the CDC provides “catch-up guidance” for children between 4 months and 4 years of age, offering detailed scenarios based on the child’s age and the number of doses previously received. This ensures that even if a child misses an initial appointment, they can still achieve the necessary immunity to prevent severe infections like respiratory distress or meningitis.

Navigating Local Care in the South Plains

Given my background as an Executive Geo-Journalist focusing on community health trends, I recognize that when a disease like Hib resurges, the immediate reaction is often confusion about where to turn. If you are concerned about your child’s immunization status or are seeing symptoms of upper respiratory infection in the Lubbock area, you need a coordinated approach with specific types of local professionals.

Board-Certified Pediatricians

When seeking a provider for Hib vaccinations, look for practitioners who adhere strictly to the CDC’s age-based recommendations. Ensure they can provide a clear record of whether your child received a monovalent vaccine (Hib-only) or a combination vaccine (such as Pentacel®), as this determines whether the booster dose will be the third or fourth shot in the series.

Pediatric Specialized Care Facilities

In the event of emergency symptoms—such as high fever, difficulty swallowing, or respiratory distress—residents should prioritize facilities equipped for pediatric emergencies. Look for institutions with dedicated pediatric intensive care units (PICU) and the capacity to perform emergency airway interventions if epiglottitis is suspected.

Community Health Liaison Officers

For families who may be hesitant about vaccines or are struggling to access the full series, seek out public health navigators. These professionals can help you interpret the CDC’s catch-up guidance and connect you with local clinics that offer the specific conjugate vaccines required for children under five.

Ready to find trusted professionals? Browse our complete directory of top-rated healthcare providers in the lubbock area today.